1
0
0
(1 - 25 von 26
)
minutes of the 9th European MCL Network conferenceTaylor & Francis Online
www.tandfonline.com
von M Dreyling · · Zitiert von: 25 — Eva Hoster Department of Medicine III, University Hospital Großhadern/LMU Munich, Germany. ,. Silvia Bea Hematopathology Unit, Department of Pathology, ...
Follicular dendritic cells in follicular lymphoma and types of ...Archive ouverte HAL
hal.science
von MK Jin · · Zitiert von: 30 — Mi Kyung Jin, Eva Hoster, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, et al.. Follicu- lar dendritic cells in follicular ...
Validation of POD24 as a robust early clinical end point of ...
ashpublications.org
von C Casulo · · Zitiert von: 9 — Eva Hoster,. Eva Hoster. 3Department of Internal Medicine III, Ludwig-Maximilians University Hospital, Campus Grosshadern, Munich, Germany; ... › blood
Long-term follow-up of cytogenetically normal CEBPA ...
jhoonline.biomedcentral.com
von F Pastore · · Zitiert von: 51 — Friederike Pastore, Daniela Kling, Eva Hoster, Annika Dufour, Nikola P Konstandin, Stephanie Schneider, Wolfgang Hiddemann & Karsten ... › ...
Ki-67 as a prognostic marker in mantle cell lymphoma ...
link.springer.com
von W Klapper · · Zitiert von: 173 — Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann & Martin Dreyling. Department of Pathology, Radboud University Nijmegen Medical Centre, ... › article
Bendamustine or high-dose cytarabine-based induction with ...pubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
von D Villa · · Zitiert von: 3 — Diego Villa , Eva Hoster , Olivier Hermine , Wolfram Klapper , Michal Szymczyk , André Bosly , Michael Unterhalt , Lisa M Rimsza , Colleen A ...
Age-dependent frequencies of NPM1 mutations and FLT3-ITD ...
www.infona.pl
von F Schneider · · Zitiert von: 127 — Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML). Friederike Schneider, Eva Hoster, Stephanie Schneider, ... › resource
A Clinical Prognostic Model Based on Machine Learning from ...
research.rug.nl
von GM Zaccaria · · Zitiert von: 2 — Gian Maria Zaccaria*, Simone Ferrero, Eva Hoster, Roberto Passera, Andrea Evangelista, Elisa Genuardi, Daniela Drandi, Marco Ghislieri, ... › publications
An individual patient-level analysis of multiple randomized trials
experts.umn.edu
von Q Shi · · Zitiert von: 93 — ... Tina Nielsen, Sabine De Bedout, Tommy Fu, Nancy Valente, Nathan H. Fowler, Eva Hoster, Marco Ladetto, Franck Morschhauser Show 3 others › thirty-mo...
Follicular dendritic cells in follicular lymphoma and types of ...
hal.archives-ouvertes.fr
von MK Jin · · Zitiert von: 30 — Mi Kyung Jin, Eva Hoster, Martin Dreyling, Michael Unterhalt, Wolfgang Hiddemann, et al.. Follicular dendritic cells in follicular lymphoma and types of ... › ha...
Genomic and microenvironmental landscape of stage I ...
pubmed.ncbi.nlm.nih.gov
von GT Los-de Vries · — ... Birgitta Sander , Andreas Rosenwald , Maria Calaminici , Eva Hoster , Wolfgang Hiddemann , Philippe Gaulard , Gilles Salles , Heike Horn ... von E Hoster · · Zitiert von: 2 — The FLIPI nowadays: validation and modification. Blood Jul 5;132(1):3-4. doi: blood Author. Eva Hoster. Affiliation. › ...
Prognostic Significance of MYC Rearrangement and ...White Rose University Consortium
eprints.whiterose.ac.uk
von A Rosenwald · · Zitiert von: 155 — John Raemaekers, PhD18; Norbert Schmitz, MD19; Fabrice Jardin, PhD20; Wendy B.C. Stevens, MD21; Eva Hoster, PhD22;.
Mantle Cell Lymphoma: an EU-MCL and LYSA study Minimal ...
www.haematologica.org
von M Cheminant · · Zitiert von: 55 — Delarue, Eva Hoster, Martin Dreyling, Vahid Asnafi, Olivier Hermine,. Cheze, Laurence Sanhes, Fabrice Jardin, François Lefrère, Richard. › article › view
Speech Production Quality of Cochlear Implant Users with ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von S Ruff · · Zitiert von: 26 — Authors. Suzan Ruff , Tobias Bocklet, Elmar Nöth, Joachim Müller, Eva Hoster, Maria Schuster. Affiliation. 1 ORL Clinic Frankfurt/Oder, Frankfurt/Oder, ... von T Nickel · · Zitiert von: 45 — ... Verena Drexel, Gernot Hertel, Arno Schmidt-Trucksäss, Claudia Summo, Zeljka Sisic, Marius Lambert, Eva Hoster, Martin Halle, Michael Weis ...
The CAR-HEMATOTOX risk-stratifies patients for severe ...KOBV
opus4.kobv.de
von K Rejeski · · Zitiert von: 18 — ... Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L Locke, ...
Treatment of Older Patients With Mantle Cell Lymphoma ...rug.nl
research.rug.nl
von HC Kluin-Nelemans · · Zitiert von: 68 — Hanneke C. Kluin-Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Christian H. Geisler, Marek Trneny, Stephan Stilgenbauer, ...
MicroRNAs as Biomarkers for Acute Atrial Remodeling in ...
journals.plos.org
von S Clauss · · Zitiert von: 87 — Eva Hoster,. Affiliation Institute for Medical Informatics Biometry and Epidemiology, Ludwig-Maximilians-UniversitätMünchen, Munich, Germany. › plosone › article › journal.pone....
Validation of POD24 As a Robust Early Clinical Endpoint of ...
moh-it.pure.elsevier.com
von C Casulo · · Zitiert von: 9 — Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard Hochster, Wolfgang Hiddemann, Robert E Marcus, Eva K Kimby, ... › ...
a European MCL intergroup study.: MRD after ...Inserm
www.hal.inserm.fr
von C Pott · · Zitiert von: 275 — Christiane Pott, Eva Hoster, Marie-Hélène Delfau-Larue, Kheira Beldjord, Sebastian Böttcher, et al.. Molecular remission is an independent predictor of ...
Validation of POD24 as a robust early clinical end PubMed
pubmed.ncbi.nlm.nih.gov
von C Casulo · · Zitiert von: 11 — Carla Casulo , Jesse G Dixon , Jennifer Le-Rademacher , Eva Hoster , Howard S Hochster , Wolfgang Hiddemann , Robert Marcus , Eva Kimby ... › ...
a European MCL intergroup study.: MRD after HAL-Inserm
www.hal.inserm.fr
von C Pott · · Zitiert von: 265 — Christiane Pott, Eva Hoster, Marie-Hélène Delfau-Larue, Kheira Beldjord, Sebastian Böttcher, et al.. Molecular remission is an independent predictor of ... › inserm-...
a study by the Lunenburg Lymphoma Biomarker Consortium ...
research.vumc.nl
von WBC Stevens · · Zitiert von: 32 — ... Andreas Rosenwald, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Luc Xerri, Gilles Salles, Wolfram Klapper, Michael Pfreundschuh, ... › prognost...
Treatment of Older Patients With Mantle Cell Lymphoma (MCL ...
research.vumc.nl
von HC Kluin-Nelemans · · Zitiert von: 57 — Hanneke C. Kluin-Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Christian H. Geisler, Marek Trneny, Stephan Stilgenbauer, ... › treatmen...
Update on the molecular pathogenesis and clinical treatment ...
research-repository.uwa.edu.au
von M Dreyling · · Zitiert von: 54 — ... Christiane Pott, Georg Hess, Carlo Visco, Umberto Vitolo, Pavel Klener, Igor Aurer, Michael Unterhalt, Vincent Ribrag, Eva Hoster, Olivier Hermine. › ...
Alle Infos zum Namen "Eva Hoster"
sortiert nach Relevanz / Datum